943-P: Improvement in Glycemic Variability with Dulaglutide Therapy Evaluated by Continuous Glucose Monitoring System: A Real-World Experience of Indian Patients with Type 2 DM

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 943-P
Author(s):  
SONALI A. PATANGE
Keyword(s):  
Monitoring System ◽  
Continuous Glucose Monitoring ◽  
Real World ◽  
Glucose Monitoring ◽  
Glycemic Variability ◽  
Continuous Glucose Monitoring System ◽  
System A ◽  
Type 2 Dm ◽  
Indian Patients

Peritoneal dialysis – risk factor for glycemic variability assessed by continuous glucose monitoring system

2014 ◽  
Vol 21 (1) ◽  
pp. 47-54 ◽  
Author(s):  
Simona Popa ◽  
Cristina Văduva ◽  
Maria Moţa ◽  
Eugen Moţa
Keyword(s):  
Risk Factor ◽  
Peritoneal Dialysis ◽  
Monitoring System ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Glycemic Variability ◽  
Continuous Glucose Monitoring System ◽  
Diabetic Patients ◽  
Type 2 Diabetic

Abstract Background and Aims. Peritoneal dialysis (PD) is accompanied by a multitude of factors that influence glycemic variability, and HbA1c does not detect dynamic glucose changes. In this study we wanted to assess glycemic variability, using a 72-hour continuous glucose monitoring system (CGMS), in 31 patients stratified according to the presence of type 2 diabetes and PD. Materials and Methods. The study included 31 patients (11 type 2 diabetic PD patients, 9 non diabetic PD patients and 11 type 2 diabetic patients without PD). Glycemic variability was assessed on CGM readings by: Mean Amplitude of Glycemic Excursion (MAGE), Mean of Daily Differences (MODD), Fractal Dimensions (FD), Mean Interstitial Glucose (MIG), Area Under glycemia Curve (AUC), M100, % time with glucose >180/<70 mg/dl. Results. The PD diabetic patients presented AUC, MIG and inter-day glycemic variability (MODD) significantly higher than diabetic patients without PD. In PD patients, the type of dialysis fluid in the nocturnal exchange and peritoneal membrane status did not significantly influence glycemic variability. Conclusions. CGMS is more useful than HbA1c in quantifying the metabolic imbalance of PD patients. PD induces inter-day glycemic variability and poor glycemic control, thus being a potential risk factor for chronic complications progression in diabetic patients.

Accuracy of continuous glucose monitoring system during exercise in type 2 diabetes

2012 ◽  
Vol 98 (3) ◽  
pp. e36-e39 ◽  
Author(s):  
Franciele R. Figueira ◽  
Daniel Umpierre ◽  
Jorge P. Ribeiro ◽  
Pedro S. Tetelbom ◽  
Nicoli T. Henn ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Monitoring System ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Continuous Glucose Monitoring System

Gestational diabetes mellitus and continuous glucose monitoring system. A prospective study.

2018 ◽  
Author(s):  
Rosa Marquez-Pardo ◽  
Maria-Gloria Baena-Nieto ◽  
Lourdes Garcia-Garcia-Doncel ◽  
Concepcion Cruzado-Begines ◽  
Isabel-Maria Torres-Barea
Keyword(s):  
Diabetes Mellitus ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Prospective Study ◽  
Monitoring System ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Continuous Glucose Monitoring System ◽  
System A ◽  
A Prospective Study
Sign in / Sign up

Export Citation Format

Share Document